Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/12/2014 - 04/27/2017

This course is closed. Please look for other available products in CPNP University.

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Bipolar disorder is a common, chronic, and often disabling psychiatric condition, in which patients experience an irregular pattern of acute mood episodes and varying degrees of inter-episode recovery. Historically, medications used to treat bipolar disorder such as lithium, valproic acid, and carbamazepine were termed mood stabilizers and medications used to treat schizophrenia were termed antipsychotics. As clinical practice evolves, the increasing role for second-generation antipsychotics in the management of bipolar disorder remains controversial. In this session, two international experts will debate the issue of whether antipsychotics are truly “mood stabilizing” agents effective for the treatment of new mood episodes.


Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Nassir Ghaemi, MD, MPH
Joseph Goldberg, MD

View biographical information and disclosures

Learning Objectives

  1. Compose definitions of “mood stabilizer” and “antipsychotic.”
  2. Compare the use of these terms by clinicians, regulators and marketeers.
  3. Compare characteristics of relapse vs recurrence in bipolar episodes.
  4. Contrast the advantages and disadvantages of different study designs which have been used to evaluate the role of antipsychotics in prophylaxis of bipolar episodes.
  5. Analyze the published data supporting or refuting the role of antipsychotics and traditional agents as “mood stabilizers.”
  6. Judge whether antipsychotics are mood stabilizers in the maintenance treatment of bipolar disorder based on the information provided in this program.

Continuing Education Credit and Disclosures

Activity Dates: 06/12/2014 - 04/27/2017
ACPE Contact Hours: 2.0
ACPE Number: 0284-0000-14-006-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 2.0 contact hours (0.20 CEUs) of application-based continuing education credit. The ACPE universal program number assigned to this course is 0284-0000-14-006-H01-P (2.0 contact hours).

Grant Support

This activity is supported by an educational grant from Sunovion Pharmaceuticals, Inc. and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.